Sintilimab Combined With Ipilimumab (N01) Plus AG as First-line Therapy for uBTC.

Name: Sintilimab Combined With Ipilimumab (N01) Plus AG as First-line Therapy for uBTC.
License: Public Domain

Tianjin Medical University Cancer Institute and Hospital

ClinicalTrials.gov · Datasets · License: Public Domain

biliary tract cancers (btc)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 407737
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.